1,2-bis(5-amidino-2-benzimidazolyl)ethane has been researched along with epiroprim in 1 studies
Studies (1,2-bis(5-amidino-2-benzimidazolyl)ethane) | Trials (1,2-bis(5-amidino-2-benzimidazolyl)ethane) | Recent Studies (post-2010) (1,2-bis(5-amidino-2-benzimidazolyl)ethane) | Studies (epiroprim) | Trials (epiroprim) | Recent Studies (post-2010) (epiroprim) |
---|---|---|---|---|---|
6 | 0 | 0 | 30 | 0 | 2 |
Protein | Taxonomy | 1,2-bis(5-amidino-2-benzimidazolyl)ethane (IC50) | epiroprim (IC50) |
---|---|---|---|
Dihydrofolate reductase | Mycobacterium avium | 0.0041 | |
Dihydrofolate reductase | Homo sapiens (human) | 0.2 | |
Dihydrofolate reductase | Escherichia coli K-12 | 2.6 | |
Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | 0.48 | |
Dihydrofolate reductase | Pneumocystis carinii | 2.3489 | |
Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.48 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.4683 | |
Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0815 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Queener, SF | 1 |
1 review(s) available for 1,2-bis(5-amidino-2-benzimidazolyl)ethane and epiroprim
Article | Year |
---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship | 1995 |